Skip to main content

Rehan Verjee

Board Member

Rehan Verjee served as President of EMD Serono and Global Head of the Innovative Medicine Franchises for Merck KGaA until March 2021. At Merck KGaA Rehan led the North American biopharmaceutical business across the U.S. and Canada in addition to leading the global oncology and neurology & immunology specialty medicine franchises for the healthcare business. Prior to this role, he served as Executive Vice President, Chief Marketing and Strategy Officer, leading the global franchises of oncology, neurology & immunology, and infertility, in addition to global business development, market access, strategy and portfolio management, marketing operations and the medical device and services unit. Prior to this, he led the Canadian operations as Managing Director of EMD Serono Canada. Rehan is currently a member of the board of directors of Massachusetts Biotechnology Council. He holds a master’s degree in Molecular and Cellular Biochemistry from the University of Oxford in the U.K.